Fact Sheet: President Donald J. Trump Announces Actions to Provide Greater Transparency and Accuracy in Prescription Drug Advertisements
Fact sheetRegulation tightenedPublished 25/09/09Open the original
Summary
President Trump directs the HHS Secretary to increase the risk information required in direct-to-consumer prescription drug advertisements and the FDA Commissioner to enforce the ban on false or misleading drug ads. The fact sheet says drug makers spent over $10 billion on direct-to-consumer advertising in 2024.
By industry
- Healthcare & Drug Pricing1 trading day+0.8%p15 stocks5 trading days−1.6%p15 stocks20 trading days+2.5%p15 stocks
“ensuring direct-to-consumer prescription drug advertisements are providing consumers with full and accurate information”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 25/09/08 | 0.0% | 0.0% |
| 25/09/09 | +1.2% | +0.4% |
| 25/09/10 | +1.0% | +0.5% |
| 25/09/11 | +2.7% | +1.3% |
| 25/09/12 | +1.5% | +1.3% |
| 25/09/15 | +0.2% | +1.8% |
| 25/09/16 | −0.3% | +1.8% |
| 25/09/17 | +0.1% | +1.8% |
| 25/09/18 | +0.2% | +2.2% |
| 25/09/19 | +0.3% | +2.2% |
| 25/09/22 | +0.2% | +2.7% |
| 25/09/23 | +1.7% | +2.2% |
| 25/09/24 | +1.8% | +1.9% |
| 25/09/25 | −0.6% | +1.4% |
| 25/09/26 | +0.7% | +2.0% |
| 25/09/29 | +1.1% | +2.2% |
| 25/09/30 | +3.3% | +2.4% |
| 25/10/01 | +6.4% | +3.0% |
| 25/10/02 | +6.1% | +3.1% |
| 25/10/03 | +6.6% | +3.1% |
| 25/10/06 | +6.0% | +3.5% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- David A. Ricks
BuyELI Lilly
BuyELI Lilly
LLY
$1.1M
1,632 sh
$1.1M
Filed 25/08/12
Traded 25/08/12
- Lucas Montarce
BuyELI Lilly
BuyELI Lilly
LLY
$494.6K
715 sh
$494.6K
Filed 25/08/15
Traded 25/08/15
- Jacob Van Naarden
BuyELI Lilly
BuyELI Lilly
LLY
$647.4K
1,000 sh
$647.4K
Filed 25/08/13
Traded 25/08/13
- Daniel Skovronsky
BuyELI Lilly
BuyELI Lilly
LLY
$634.4K
1,000 sh
$634.4K
Filed 25/08/12
Traded 25/08/12
- J. Erik Fyrwald
BuyELI Lilly
BuyELI Lilly
LLY
$564.8K
879 sh
$564.8K
Filed 25/08/12
Traded 25/08/12
- Ralph Alvarez
BuyELI Lilly
BuyELI Lilly
LLY
$500.5K
758 sh
$500.5K
Filed 25/08/14
Traded 25/08/13
- J. Erik Fyrwald
BuyELI Lilly
BuyELI Lilly
LLY
$440.4K
686 sh
$440.4K
Filed 25/08/12
Traded 25/08/12
- Gabrielle Sulzberger
BuyELI Lilly
BuyELI Lilly
LLY
$75K
117 sh
$75K
Filed 25/08/12
Traded 25/08/12
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$83M
101,112 sh
$83M
Filed 25/10/03
Traded 25/10/02
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$69.1M
90,501 sh
$69.1M
Filed 25/10/01
Traded 25/09/30
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$54.2M
63,849 sh
$54.2M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.7M
36,114 sh
$30.7M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.4M
39,863 sh
$30.4M
Filed 25/09/19
Traded 25/09/18
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$26.1M
31,102 sh
$26.1M
Filed 25/10/06
Traded 25/10/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$23.8M
28,063 sh
$23.8M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$22.7M
26,795 sh
$22.7M
Filed 25/10/08
Traded 25/10/07
- Joaquin Duato
SellJohnson & Johnson
SellJohnson & Johnson
JNJ
$22.5M
125,824 sh
$22.5M
Filed 25/08/25
Traded 25/08/22
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$21.5M
25,296 sh
$21.5M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$20.6M
24,495 sh
$20.6M
Filed 25/10/06
Traded 25/10/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$20.4M
26,647 sh
$20.4M
Filed 25/09/19
Traded 25/09/18